- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01323387
Lumbar Degenerative Disc Disease Treated With Anterior Tension Band System (ATB) With ALIF/FRA Spacer (ATB)
Lumbar Degenerative Disc Disease Treated With
Multi-center, prospective nonrandomized study of treatment for 1 and 2 level degenerative disc disease between L2 and S1. Patients will be followed for a minimum of 2 years.
The primary objective of this study to measure fusion success in patients with lumbar degenerative disc disease using the ATB and ALIF/FRA Spacer. The Secondary objective is evaluation of the patient's quality of life, pain and function.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
One or Two level (consecutive) degenerative disc disease between L2 and S1. Degenerative disc disease is defined as follows:
Chronic pain (confirmed by patient exams and history) of discogenic origin, confirmed by radiographic evidence (e.g. MRI, discogram) two or more of the following:
- Modic type 2 endplate changes on T2 weighted MRI
- high intensity zone signal on T2 weighted MRI
- positive discogram with negative controls
- dark disc (diminished T2 weighted signal)
- decreased disc height
- Has experienced pain, functional deficit and/or neurological deficit for a minimum six month period of time prior to enrollment
- Has failed to respond to non-operative treatment modalities for a minimum three month period of time prior to enrollment
- Skeletally mature and at least 18 years of age
- Signs the approved Informed Consent Document
- Is available for long term follow-up and interval visits
Exclusion Criteria:
- Has more than 2 levels to be instrumented
- Has had a previous fusion attempt at the involved level(s)
- Has had more than two previous open, lumbar spine surgical procedures at the involved level(s)
- Currently implanted with anterior instrumentation at the involved level(s)
- Patient would be classified as morbidly obese BMI > 35
- Active localized or systemic infection
- Presence of a disease entity or condition which significantly affects the possibility of bony fusion (e.g., osteoporosis, metastatic cancer, long-term use of steroids, etc.)
- Has an immunosuppressive disorder
- Pregnant or interested in becoming pregnant during the study.
- Has a known sensitivity to device materials
- Mentally incompetent or prisoner
- Currently a participant in another study for the same indications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Treatment
Interbody fusions with Anterior Plating
|
allograft spacer + anterior plate
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Subjects With Successful Radiographic Fusion
Time Frame: 24 Months
|
CT Scans and plain film x-rays will be evaluated.
Demonstration of bridging trabecular bone through or external to the allograft spacer will be the measure of success.
|
24 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life Using the SF-12 Scale Physical Health Component Score (PCS). Number of Subjects Who Achieved 15% Improvement in PCS Compared to Baseline.
Time Frame: 24 Months
|
Quality of Life using the SF-12 Scale Physical Health Component Score (PCS).
The PCS is a measurement of health status with a range of 0-100.
A higher score indicates less disability.
|
24 Months
|
Pain Scores on the Numeric Rating Scale (NRS)
Time Frame: Baseline and 24 Months
|
The Numeric Rating Scale (NRS) is a measurement of pain from a value of 0 (no pain) to a value of 10 (worst pain)
|
Baseline and 24 Months
|
Oswestry Disability Index (ODI): Number of Subjects Who Achieved a 15% Improvement in ODI Compared to Baseline
Time Frame: 24 Months
|
The outcome measure is the number of subjects who achieved a 15% improvement in ODI compared to baseline.
The ODI is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.
ODI scores range from 0 to 100 with 0 equating to No Disability and 100 equating to the Maximum Disability Possible
|
24 Months
|
Quality of Life Using SF-12 Scale (MCS): Number of Subjects Who Achieved 15% Improvement in MCS Compared to Baseline
Time Frame: Baseline and 24 Months
|
The outcome measure is the number of subjects who achieved a 15% improvement in MCS compared to baseline.
The MCS (Mental Component Score) is a measurement of health status with a range of 0 to 100.
A higher score indicates less disability.
|
Baseline and 24 Months
|
SF-12 Physical Composite Score (PCS) Summary
Time Frame: Baseline and 24 Months
|
The PCS (Physical Component Score) is a measurement of health status with a range of 0 to 100.
A higher score indicates less disability.
|
Baseline and 24 Months
|
SF-12 Mental Composite Score (MCS) Summary
Time Frame: Baseline and 24 Months
|
The MCS (Mental Component Score) is a measurement of health status with a range of 0 to 100.
A higher score indicates less disability.
|
Baseline and 24 Months
|
Oswestry Disability Index (ODI) Summary
Time Frame: Baseline and 24 Months
|
The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.
The scores can range from 0 to 100 with 0 equating to No Disability and 100 equating to the Maximum Disability Possible
|
Baseline and 24 Months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kirkham Wood, MD, Mass. General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1255
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Degenerative Disc Disease
-
NuVasiveCompleted
-
NuVasiveCompleted
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
NYU Langone HealthActive, not recruitingLumbar Degenerative Disc DiseaseUnited States
-
Bioventus LLCTerminatedLumbar Degenerative Disc Disease
-
Justin Parker Neurological InstituteTerminated
-
OAD OrthopaedicsCentral DuPage Hospital; Halifax Biomedical Inc.Unknown
-
Eisai China Inc.Completed
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Spineology, IncCompletedLumbar Degenerative Disc DiseaseUnited States
Clinical Trials on Interbody Fusion
-
The London Spine CentreUnknownSpinal Stenosis | Degenerative SpondylolisthesisCanada
-
Kyungpook National University HospitalUnknownDegenerative Spondylolisthesis | Transforaminal Lumbar Interbody FusionKorea, Republic of
-
ExactechTerminatedDegenerative Disc Disease | Spondylolisthesis | StenosisUnited States
-
National Taiwan University HospitalBaui Biotech Co., Ltd.RecruitingCervical Disc DegenerationTaiwan
-
Induce Biologics USA Inc.Not yet recruitingDegenerative Disc Disease | Spinal Stenosis | Degenerative SpondylolisthesisUnited States
-
University of British ColumbiaNot yet recruitingIsthmic Spondylolisthesis
-
Medtronic Spinal and BiologicsTerminatedLow Back Pain | Intervertebral Disc Displacement | Spinal Stenosis | SpondylolisthesisGermany, Netherlands
-
Mesoblast, Ltd.CompletedDegenerative Disc Disease | Spinal Stenosis | Degenerative SpondylolisthesisUnited States
-
Spine and Scoliosis Research AssociatesEnrolling by invitationDegenerative Disc Disease (DDD)United States
-
3SpineMCRARecruiting